A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970).

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 164, Issue , 2003, Pages 349-352

  Swami, Srilatha ^a   Zhao, Xian Yan ^a   Sarabia, Stephen ^a   Siu Caldera, Mei Lung ^a   Uskokovic, Milan ^a   Reddy, Satya G ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXY 16,23 DIENE VITAMIN D3; 1,25-DIHYDROXY-16,23-DIENE VITAMIN D3; CALCITRIOL; CALCITRIOL RECEPTOR; COLECALCIFEROL; DRUG DERIVATIVE; LUCIFERASE; OSTEOCALCIN; PROSTATE SPECIFIC ANTIGEN; RETINOIC ACID RECEPTOR;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN COS1; CERCOPITHECUS; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; PATHOLOGY; PROSTATE TUMOR; SACCHAROMYCES CEREVISIAE; TRANSACTIVATION; TWO HYBRID SYSTEM;

ANIMALS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CERCOPITHECUS AETHIOPS; CHOLECALCIFEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COS CELLS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LUCIFERASES; MALE; OSTEOCALCIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; SACCHAROMYCES CEREVISIAE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0642305926     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-55580-0_24     Document Type: Article

References (0)